Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2120-2127

  Maekawa, Yoichi ^a   Himeno, Kunisuke ^a   Ishikawa, Hiroyuki ^a   Hisaeda, Hajime ^a   Sakai, Tohru ^a   Dainichi, Teruki ^a   Asao, Tetsuji ^b   Good, Robert A ^c   Katunuma, Nobuhiko ^d  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CD4 ANTIGEN; CYSTEINE PROTEINASE INHIBITOR; EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; LYSOSOME ENZYME; MONOCLONAL ANTIBODY CD3; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DISEASE RESISTANCE; FEMALE; HELPER CELL; IMMUNE RESPONSE; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, PROTOZOAN; CATHEPSIN B; CELL DIFFERENTIATION; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; ENZYME ACTIVATION; FEMALE; IMMUNITY, NATURAL; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; LYSOSOMES; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, SCID; RECURRENCE; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 0032167368     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Allen, P. M., G. R. Matsueda, R. J. Evans, J. B. Dunbar, Jr., G. R. Marshall, and E. R. Unanue. 1987. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature 327:713.
2. Srinivasan, M., E. W. Marsh, and S. K. Pierce. 1991. Characterization of naturally processed antigen bound to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 88:7928.
3. Matsunaga, Y., T. Saibara, H. Kido, and N. Katunuma. 1993. Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett. 324:325.
4. Mizuochi, Y., S.T. Yee, M. Kasai, D. Muno, and E. Kominami. 1994. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol. Lett. 43:189.
5. Takahashi, H., K. B. Cease, and J. A. Berzofsky. 1989. Identification of proteases that process distinct epitopes on the same protein. J. Immunol. 142:2221.
6. Towatari, T., T. Nikawa, M. Murata, C. Yokoo, M. Tamai, K. Hanada, and N. Katunuma. 1991. Novel epoxysuccinyl peptides: a selective inhibitor of cathepsin B, in vivo. FEBS Lett. 280:311.
7. Marata, M., S. Miyashita, C. Yokoo, M. Tamai, K. Hanada, K. Hatayama, T. Towatari, T. Nikawa, and N. Katunuma. 1991. Novel epoxysuccinyl peptides: selective inhibitors of cathepsin B, in vitro. FEBS Lett. 280:307.
8. Katunuma, N., and Y. Matsunaga. 1996. Mechanisms and regulations of exogenous antigen processing and its signal transduction. Clin. Immunol. 28:738.
9. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
10. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon g or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
11. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
12. + T cells. Annu. Rev. Immunol. 12:635.
13. Scott, P. 1991. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.
14. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182.
15. Scott, P., E. Pearce, P. Natovitz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139:221.
16. Barrett, A. J., and H. Kirschke. 1981. Proteases of diverse origin and function: cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 80:535.
17. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Pro. Natl. Acad. Sci. USA 90:10188.
18. Gros, G. L., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
19. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
20. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 and IFN-γ direct the development of distinct subunits of helper T cells. Fed. Proc. 4:2020.
21. + T cells from from ab TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent. Int. Immunol. 5:1119.
22. Belosevic, M., D. S. Finbloom, P. H. van der Meide, M. V. Slayter, and C. A. Nacy. 1989. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266.
23. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: evidence for a T cell-dependent, interferon γ-independent mechanism. J. Exp. Med. 171:115.
24. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
25. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
26. H1 cells. Immunol. Today 14:335.
27. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88.
28. H2 response and in immunoglobulin E production. Science 270:1845.
29. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285.
30. Corry, D. B., S. L. Reiner, P. S. Linsley, and R. M. Locksley. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effecter cells in experimental leishmaniasis. J. Immunol. 153:4142.
31. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
32. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
33. Rodriguez, G. M., and S. Diment. 1992. Role of cathepsin D in antigen presentation of ovalbumin. J. Immunol. 149:2894.
34. Bennett, K., T. Levine, J. S. Ellis, R. J. Peanasky, I. M. Samloff, J. Kay and B. M. Chain. 1992. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22:1519.